Award recordCONTRACT

IMMUCOR INC

PIID VA25912F0124· VHA· NETWORK CONTRACT OFFICE 19 (36C259)· 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS· FY2012· $217,592 net obligations· UEI KV8AGJX7NMZ7· GA

Description

IGF::OT::IGF OPTION YEAR 3 DENVER VAMC BLOOD BANK REAGENTS

Base award description: BLOOD BANK REAGENTS.THE REAGENT ANTI-SERA, CELLS&SUPPLY PRODUCTS ARE REQUIRED TO PERFORM IMMUNOHEMATOLOGICAL TESTING FOR THE OPERATION OF THE VAECHCS BLOOD BANK.

First action · last action
2012-03-28 · 2019-06-26
Transactions
11
First transaction's obligation
$90,000
Base + all options value (sum of deltas)
$217,592
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
2
SDVOSB flag on record
No
Parent IDV
V797P5944X
NAICS
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING

Modification chain · 11 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$340,673$0Base award · 2012-03-28 · this action $90,000 · running total $90,000Modification P00001 · 2013-03-18 · this action $93,375 · running total $183,375Modification P00002 · 2014-03-06 · this action $96,877 · running total $280,252Modification P00004 · 2014-08-07 · this action $0 · running total $280,252Modification P00003 · 2014-08-14 · this action -$38,922 · running total $241,330Modification P00005 · 2014-11-19 · this action -$48,540 · running total $192,790Modification P00006 · 2015-03-20 · this action $100,509 · running total $293,299Modification P00007 · 2015-08-10 · this action -$56,904 · running total $236,395Modification P00008 · 2016-01-26 · this action $104,279 · running total $340,673Modification P00009 · 2016-05-11 · this action -$63,832 · running total $276,841Modification P00010 · 2019-06-26 · this action -$59,249 · running total $217,592
  • Base2012-03-28+$90,000= $90,000
  • Mod P000012013-03-18+$93,375= $183,375
  • Mod P000022014-03-06+$96,877= $280,252
  • Mod P000042014-08-07+$0= $280,252
  • Mod P000032014-08-14-$38,922= $241,330
  • Mod P000052014-11-19-$48,540= $192,790
  • Mod P000062015-03-20+$100,509= $293,299
  • Mod P000072015-08-10-$56,904= $236,395
  • Mod P000082016-01-26+$104,279= $340,673
  • Mod P000092016-05-11-$63,832= $276,841
  • Mod P000102019-06-26-$59,249= $217,592
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2012-03-28+$90,000$90,000BLOOD BANK REAGENTS.THE REAGENT ANTI-SERA, CELLS&SUPPLY PRODUCTS ARE REQUIRED TO PERFORM IMMUNOHEMATOLOGICAL T…
Mod P00001· EXERCISE AN OPTION2013-03-18+$93,375$183,375BLOOD BANK REAGENTS.THE REAGENT ANTI-SERA, CELLS&SUPPLY PRODUCTS ARE REQUIRED TO PERFORM IMMUNOHEMATOLOGICAL T…
Mod P00002· EXERCISE AN OPTION2014-03-06+$96,877$280,252BLOOD BANK REAGENTS.THE REAGENT ANTI-SERA, CELLS&SUPPLY PRODUCTS ARE REQUIRED TO PERFORM IMMUNOHEMATOLOGICAL T…
Mod P00004· EXERCISE AN OPTION2014-08-07+$0$280,252BLOOD BANK REAGENTS.THE REAGENT ANTI-SERA, CELLS&SUPPLY PRODUCTS ARE REQUIRED TO PERFORM IMMUNOHEMATOLOGICAL T…
Mod P00003· EXERCISE AN OPTION2014-08-14−$38,922$241,330BLOOD BANK REAGENTS.THE REAGENT ANTI-SERA, CELLS&SUPPLY PRODUCTS ARE REQUIRED TO PERFORM IMMUNOHEMATOLOGICAL T…
Mod P00005· CHANGE ORDER2014-11-19−$48,540$192,790DECREASE FOR BLOOD BANK REAGENTS.THE REAGENT ANTI-SERA, CELLS&SUPPLY PRODUCTS ARE REQUIRED TO PERFORM IMMUNOHE…
Mod P00006· EXERCISE AN OPTION2015-03-20+$100,509$293,299IGF::OT::IGF OPTION YEAR 3 DENVER VAMC BLOOD BANK REAGENTS
Mod P00007· CHANGE ORDER2015-08-10−$56,904$236,395IGF::OT::IGF OPTION YEAR 3 DENVER VAMC BLOOD BANK REAGENTS
Mod P00008· EXERCISE AN OPTION2016-01-26+$104,279$340,673IGF::OT::IGF OPTION YEAR 3 DENVER VAMC BLOOD BANK REAGENTS
Mod P00009· FUNDING ONLY ACTION2016-05-11−$63,832$276,841IGF::OT::IGF OPTION YEAR 3 DENVER VAMC BLOOD BANK REAGENTS
Mod P00010· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2019-06-26−$59,249$217,592IGF::OT::IGF OPTION YEAR 3 DENVER VAMC BLOOD BANK REAGENTS

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI KV8AGJX7NMZ7)

AwardOffice · PSC / listingNet obligationsFY
36C24526F0359245-NETWORK CONTRACT OFFICE 5 (36C245) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES$65,480FY2026
36C24526F0345245-NETWORK CONTRACT OFFICE 5 (36C245) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES$65,480FY2026
36C24926N0126249-NETWORK CONTRACT OFFICE 9 (36C249) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$37,477FY2026
36C24725F0271247-NETWORK CONTRACT OFFICE 7 (36C247) · H266 · EQUIPMENT AND MATERIALS TESTING- INSTRUMENTS AND LABORATORY EQUIPMENT$158,618FY2025
36C25025F0706250-NETWORK CONTRACT OFFICE 10 (36C250) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES$201,180FY2025
36C25025F0696250-NETWORK CONTRACT OFFICE 10 (36C250) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES$66,971FY2025

Other recipients under 6550 from NETWORK CONTRACT OFFICE 19 (36C259) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C25926N0457BECTON, DICKINSON AND COMPANYNETWORK CONTRACT OFFICE 19 (36C259)$147,256FY2026
36C25926N0353QIAGEN, LLCNETWORK CONTRACT OFFICE 19 (36C259)$88,310FY2026
36C25926N0292FISHER SCIENTIFIC COMPANY L.L.C.NETWORK CONTRACT OFFICE 19 (36C259)$165,000FY2026
36C25926N0280ALBA BIOSCIENCE, INC.NETWORK CONTRACT OFFICE 19 (36C259)$64,078FY2026
36C25926N0316POLYMEDCO CANCER DIAGNOSTIC PRODUCTS LLCNETWORK CONTRACT OFFICE 19 (36C259)$50,343FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25912F0124_3600_V797P5944X_3600 · retrieved 2026-09-27.